TVM Capital Life Science Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 10

Professionals

  • Investments
  • 77

  • Portfolio
  • 22

  • Exits
  • 48

Exits

TVM Capital Life Science General Information

Company Description

Founded in 1983, TVM Capital Life Science is a venture capital investment firm headquartered in Munich, Germany. The firm seeks to invest in biopharma, diagnostic, med-tech, and digital health companies in Europe, North America, and Asia.

Business Details

Website
tvm-capital.com
Formerly Known As
Blitz 07-749 GmbH
Year Founded
1983
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Corporate Office
  • Ottostraße 4
  • 80333 Munich
  • Germany
+49 089

TVM Capital Life Science Investments (77)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Anciata Therapeutics 10-Apr-2025 Joint Venture Drug Discovery Startup
Egg Medical 01-Mar-2025 Medical Supplies Generating Revenue
RejuvenAir 18-Sep-2024 Therapeutic Devices Generating Revenue
Leon Nanodrugs 06-Aug-2024 Drug Discovery Generating Revenue
Jacobian 22-Apr-2024 Decision/Risk Analysis Generating Revenue
Vektor Medical 19-Feb-2024 Decision/Risk Analysis Clinical Trials - General
myo 31-Jan-2024 Other Healthcare Technology Systems Generating Revenue
Mage Biologics 20-Jul-2023 Drug Discovery Pre-Clinical Trials
TargaGenix 28-Feb-2023 Later Stage VC Drug Discovery Generating Revenue
Esperas Pharma 21-Feb-2023 Later Stage VC Biotechnology Out of Business
You’re viewing 10 of 77 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TVM Capital Life Science Exits (48)

Company Name Exit Date Exit Type Exit Size
Esperas Pharma 25-Apr-2026 Out of Business
Centogene 13-Nov-2024
Ixchelsis 26-May-2024
Modulate Therapeutics 06-Oct-2023
Direvo 07-Oct-2021
Rapid Micro Biosystems 15-Jul-2021
Mediti Pharma 15-Apr-2021
F-Star Therapeutics 20-Nov-2020
Centogene 10-Jul-2020 Public Investment 2nd Offering
Proteon Therapeutics 09-Jan-2020 Merger/Acquisition
You’re viewing 10 of 48 exits. Get the full list »

TVM Capital Life Science Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore TVM Capital Life Science‘s full profile, request access.

Request a free trial

TVM Capital Life Science Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

TVM Capital Life Science Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Tvm Vi Lsv Beteiligungsgesellschaft mbH Munich, Germany 2004
Tvm Iv Beteiligungsgesellschaft mbH Munich, Germany 2000

TVM Capital Life Science FAQs

  • What is TVM Capital Life Science?

    Founded in 1983, TVM Capital Life Science is a venture capital investment firm headquartered in Munich, Germany.

  • When was TVM Capital Life Science founded?

    TVM Capital Life Science was founded in 1983.

  • Where is TVM Capital Life Science headquartered?

    TVM Capital Life Science is headquartered in Munich, Germany.

  • What is TVM Capital Life Science's total asset value?

    TVM Capital Life Science has around in total assets under management.

  • How many investments has TVM Capital Life Science made?

    TVM Capital Life Science has made 77 investments.

  • What has TVM Capital Life Science invested in?

    TVM Capital Life Science has made numerous investments in companies like Anciata Therapeutics, Egg Medical, and RejuvenAir within the Drug Discovery, Medical Supplies, and Therapeutic Devices industries.

  • What has TVM Capital Life Science invested in recently?

    TVM Capital Life Science's latest investment was on 10-Apr-2025 in Anciata Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process